GGHC
GBIO

Gilder Gagnon Howe & Co’s Generation Bio GBIO Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-7,074
Closed -$1.49M – 345
2020
Q2 		$1.49M Buy
+7,074
New +$1.58M 0.01% 227

Other funds holding GBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Gilder Gagnon Howe & Co's GBIO Position: Q3 2020 in Review

Gilder Gagnon Howe & Co sold out of Generation Bio (GBIO) in Q3 2020, closing a stake of 7,074 shares — an estimated $1.49M sold.

Gilder Gagnon Howe & Co first reported a position in GBIO in Q2 2020 and held it in 1 quarter. The position peaked at $1.49M in Q2 2020. 53 funds tracked by Wall St. Rank hold GBIO as of Q3 2020.

  • Gilder Gagnon Howe & Co reported no remaining Generation Bio position as of Q3 2020 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 7,074 Generation Bio shares in Q3 2020, an estimated $1.49M.
  • Gilder Gagnon Howe & Co first reported a position in Generation Bio in Q2 2020 and held it in 1 quarter.
  • Gilder Gagnon Howe & Co's Generation Bio position peaked at $1.49M in Q2 2020.
  • 53 funds tracked by Wall St. Rank held Generation Bio as of Q3 2020.

Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2020, filed 16 Nov 2020.